XML 38 R31.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stockholders’ Equity (Tables)
3 Months Ended
Mar. 31, 2024
Stockholders’ Equity [Abstract]  
Schedule of Restricted Stock Awards

Based on the closing market price of our common stock on March 31, 2024 and December 31, 2023, the aggregate intrinsic value of our restricted stock awards was as follows:

 

 

As of March 31, 2024

 

 

As of December 31, 2023

 

 

Outstanding

 

 

Vested

 

 

Outstanding

 

 

Vested

 

Aggregate intrinsic value

 

$

5,677,200

 

 

$

1,073,937

 

 

$

5,525,370

 

 

$

937,068

 

Schedule of Restricted Stock Activity

The following table summarizes the restricted stock activity for the Company’s directors and officers and employees of the Manager during the three months ended March 31, 2024 and 2023.

 

 

Three months ended
March 31,
2024

 

 

Weighted Average Grant Date
Fair Value
per Share

 

Balance at December 31, 2023

 

 

366,647

 

 

$

14.86

 

Vested

 

 

(6,647

)

 

$

16.00

 

Unvested Balance at March 31, 2024

 

 

360,000

 

 

$

14.84

 

 

 

Three months ended
March 31,
2023

 

 

Weighted Average Grant Date
Fair Value
per Share

 

Balance at December 31, 2022

 

 

80,984

 

 

$

15.71

 

Vested

 

 

(6,952

)

 

$

16.00

 

Forfeited

 

 

(417

)

 

$

16.00

 

Unvested Balance at March 31, 2023

 

 

73,615

 

 

$

15.68